Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New model of cancer syndrome could lead to treatments

05.01.2005


Scientists from MIT’s Center for Cancer Research have developed a new mouse model that closely resembles Li-Fraumeni Syndrome (LFS) in humans, a syndrome that predisposes those affected to a broad range of cancers. Some 95 percent of LFS patients develop cancer by age 65.



This work, which was reported in the Dec. 17 issue of Cell, could lead to a treatment for LFS and aid in the development of treatments for other cancers.

The research shows that a single point mutation in the tumor suppressor gene p53 yields a mouse that develops a broad tumor spectrum reminiscent of LFS. Although LFS is a rare genetic disease, affecting fewer than 400 families worldwide, the p53 gene is very commonly mutated in tumors unrelated to LFS. Mutations in p53 are detected in more than 50 percent of all human tumors, such as colon, breast, skin, bladder and many cancers of the digestive tract. Consequently, the development of a therapy for LFS specifically targeted at p53 has the potential to be applied to a wide range of cancers.


"The LFS mouse strains, which have been many years in the making, will be extremely valuable in understanding how the common mutations in p53 contribute to tumor formation," said Tyler Jacks, David H. Koch professor of biology, director of the Center for Cancer Research and leader of the MIT team. "We expect these strains will also help us determine how to specifically treat p53 mutant tumors," explained Jacks, who is also an Investigator for the Howard Hughes Medical Institute.

Understanding the genetic basis of disease is the key to developing effective therapies in the fight against cancer, and mouse models of human cancer have played an integral role in research. However, previous attempts to create accurate mouse models of LFS by completely inactivating p53 were unsuccessful because the mice did not develop the wide range of tumors seen in human LFS patients.

In this study, two different mutations in p53 that are commonly found in human tumors were tested in the mouse. These mutations do not lead to deletion of p53, but have more subtle effects. The authors found that mice that possessed either of the two mutations in p53 developed more tumors and more different types of tumors than do mice completely lacking p53.

"By knocking out p53, the mice did not develop as many types of tumors as is typically seen with LFS," said Kenneth Olive, lead author of the paper and a graduate student in biology. "Therefore, it is important that we understand what it is about these subtle mutations that is different from simply inactivating the whole gene. More generally, if we are to truly understand human cancer, it is important that we study not just any mutation, but the right mutation."

Other MIT authors of the paper are David Tuveson, now an assistant professor at the University of Pennsylvania, biology undergraduates Zachary Ruhe and Bob Yin, and former research technician Nicholas Willis and research affiliate Denise Crowley of the Center for Cancer Research. Roderick Bronson of Tufts University School of Veterinary Medicine also contributed to this work.

The work is supported by the Howard Hughes Medical Institute and the National Cancer Institute Mouse Models of Human Cancer Consortium. Support also comes from a Koch Graduate Fellowship and a National Institutes of Health Training Grant.

Elizabeth Thomson | MIT News Office
Further information:
http://www.mit.edu

More articles from Life Sciences:

nachricht Antimicrobial substances identified in Komodo dragon blood
23.02.2017 | American Chemical Society

nachricht New Mechanisms of Gene Inactivation may prevent Aging and Cancer
23.02.2017 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

From rocks in Colorado, evidence of a 'chaotic solar system'

23.02.2017 | Physics and Astronomy

'Quartz' crystals at the Earth's core power its magnetic field

23.02.2017 | Earth Sciences

Antimicrobial substances identified in Komodo dragon blood

23.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>